InvestorsHub Logo
icon url

churchill_21

07/20/23 9:50 PM

#612172 RE: Poor Man - #612168

Her compensation is absolutely egregious.
icon url

sentiment_stocks

07/20/23 9:54 PM

#612174 RE: Poor Man - #612168

Minor point overall, IMO, but she is also serving as the CFO as well.
icon url

hoffmann6383

07/20/23 9:54 PM

#612175 RE: Poor Man - #612168

Sounds like you have no idea about her pay. You were wrong about any bonuses - she has taken none. It appears you have no idea about these side jobs you allege. Yet, you are confident in your assertion that she is overpaid. Sounds about right for the typical bullshit that comes from our dear friend PM.

1 unknown + misinformation + 2nd unknown = Linda overpaid

^^ standard Craigslist hire
Bullish
Bullish
icon url

Horseb4CarT

07/20/23 11:11 PM

#612181 RE: Poor Man - #612168

I guess egregious is in the eye of the beholder. LP is actually enabling a cost effective total execution of getting from zero to approvals. Here’s the logic:

1. As Senti noted, LP’s compensation covers several titles instead of paying additional individuals

2. The much greater efficiencies come from pulling off massively parallel accomplishments such as :
A. One phase 3 including and applying to US, UK, Ca, EU

B. One SAP and one base application

C. Firm ground work for tissue agnostic applicability

D. Acquired basis of automated closed system production-> scaling multiplier

I’ll stop at this point, which I think establishes the value of highly intelligent planning and the wherewithal to innovate the production and even the approval processes along with the regulatory agencies. I believe LP has been key to all this trailblazing new advances.
icon url

CrashOverride

07/20/23 11:14 PM

#612182 RE: Poor Man - #612168

Linda developed DCVax and manufacturing as well as secured global patent protection for less than the average cost of developing your typical drug. She's absolutely underpaid. I will gladly vote to increase her compensation after MHRA approval.